Cargando…

The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men

OBJECTIVES: Moderate to severe psoriasis, once regarded as merely a skin disease, is today seen as an inflammatory systemic disease. The sex ratio of the prevalence of psoriasis is balanced. In recent years several reports have documented that men receive more systemic or UV treatment than women, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hägg, David, Eriksson, Marie, Sundström, Anders, Schmitt-Egenolf, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655146/
https://www.ncbi.nlm.nih.gov/pubmed/23691076
http://dx.doi.org/10.1371/journal.pone.0063619
_version_ 1782269834631839744
author Hägg, David
Eriksson, Marie
Sundström, Anders
Schmitt-Egenolf, Marcus
author_facet Hägg, David
Eriksson, Marie
Sundström, Anders
Schmitt-Egenolf, Marcus
author_sort Hägg, David
collection PubMed
description OBJECTIVES: Moderate to severe psoriasis, once regarded as merely a skin disease, is today seen as an inflammatory systemic disease. The sex ratio of the prevalence of psoriasis is balanced. In recent years several reports have documented that men receive more systemic or UV treatment than women, and different hypotheses were made. In PsoReg, the national registry for systemic treatment of psoriasis in Sweden, we have, like other European registries, observed a predominance of men (59%), especially of men treated with biologics (63%). Biologics are a relatively new group of very effective but high-priced drugs. The objective of this study was to analyse if women are discriminated by not having the same access to the high-priced biologics. DESIGN: Population based cohort study using data from a nationwide quality register of psoriasis patients. POPULATION: 2294 patients with moderate to severe psoriasis receiving systemic treatment from a specialist in dermatology. MAIN OUTCOME MEASURES: Time to initiation of biologic treatment. A multiple Cox proportional hazard’s regression was performed, with time to initiating a biologic treatment as the outcome in order to assess the independent role of the patient’s sex in initiating such therapy. The psoriasis severity was defined as a time-varying variable. RESULTS: Men had more severe psoriasis than women according to the Psoriasis Area and Severity Index (PASI), regardless of age at enrolment, and throughout the study period. The analysis in the multiple Cox regression show that age, psoriasis severity and psoriasis arthropathy were relevant factors for initiating biologic therapy, whereas sex is not. CONCLUSIONS: Although as many women as men are believed to suffer from psoriasis, men seem to be more severely affected by psoriasis. The asymmetry in allocation of biologic therapy thereby probably reflects the differing disease activity between the sexes, and is not a discrimination against women per se.
format Online
Article
Text
id pubmed-3655146
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36551462013-05-20 The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men Hägg, David Eriksson, Marie Sundström, Anders Schmitt-Egenolf, Marcus PLoS One Research Article OBJECTIVES: Moderate to severe psoriasis, once regarded as merely a skin disease, is today seen as an inflammatory systemic disease. The sex ratio of the prevalence of psoriasis is balanced. In recent years several reports have documented that men receive more systemic or UV treatment than women, and different hypotheses were made. In PsoReg, the national registry for systemic treatment of psoriasis in Sweden, we have, like other European registries, observed a predominance of men (59%), especially of men treated with biologics (63%). Biologics are a relatively new group of very effective but high-priced drugs. The objective of this study was to analyse if women are discriminated by not having the same access to the high-priced biologics. DESIGN: Population based cohort study using data from a nationwide quality register of psoriasis patients. POPULATION: 2294 patients with moderate to severe psoriasis receiving systemic treatment from a specialist in dermatology. MAIN OUTCOME MEASURES: Time to initiation of biologic treatment. A multiple Cox proportional hazard’s regression was performed, with time to initiating a biologic treatment as the outcome in order to assess the independent role of the patient’s sex in initiating such therapy. The psoriasis severity was defined as a time-varying variable. RESULTS: Men had more severe psoriasis than women according to the Psoriasis Area and Severity Index (PASI), regardless of age at enrolment, and throughout the study period. The analysis in the multiple Cox regression show that age, psoriasis severity and psoriasis arthropathy were relevant factors for initiating biologic therapy, whereas sex is not. CONCLUSIONS: Although as many women as men are believed to suffer from psoriasis, men seem to be more severely affected by psoriasis. The asymmetry in allocation of biologic therapy thereby probably reflects the differing disease activity between the sexes, and is not a discrimination against women per se. Public Library of Science 2013-05-15 /pmc/articles/PMC3655146/ /pubmed/23691076 http://dx.doi.org/10.1371/journal.pone.0063619 Text en © 2013 Hägg et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hägg, David
Eriksson, Marie
Sundström, Anders
Schmitt-Egenolf, Marcus
The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men
title The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men
title_full The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men
title_fullStr The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men
title_full_unstemmed The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men
title_short The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men
title_sort higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655146/
https://www.ncbi.nlm.nih.gov/pubmed/23691076
http://dx.doi.org/10.1371/journal.pone.0063619
work_keys_str_mv AT haggdavid thehigherproportionofmenwithpsoriasistreatedwithbiologicsmaybeexplainedbymoreseverediseaseinmen
AT erikssonmarie thehigherproportionofmenwithpsoriasistreatedwithbiologicsmaybeexplainedbymoreseverediseaseinmen
AT sundstromanders thehigherproportionofmenwithpsoriasistreatedwithbiologicsmaybeexplainedbymoreseverediseaseinmen
AT schmittegenolfmarcus thehigherproportionofmenwithpsoriasistreatedwithbiologicsmaybeexplainedbymoreseverediseaseinmen
AT haggdavid higherproportionofmenwithpsoriasistreatedwithbiologicsmaybeexplainedbymoreseverediseaseinmen
AT erikssonmarie higherproportionofmenwithpsoriasistreatedwithbiologicsmaybeexplainedbymoreseverediseaseinmen
AT sundstromanders higherproportionofmenwithpsoriasistreatedwithbiologicsmaybeexplainedbymoreseverediseaseinmen
AT schmittegenolfmarcus higherproportionofmenwithpsoriasistreatedwithbiologicsmaybeexplainedbymoreseverediseaseinmen